194 related articles for article (PubMed ID: 12777375)
1. Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis.
Leopold JA; Walker J; Scribner AW; Voetsch B; Zhang YY; Loscalzo AJ; Stanton RC; Loscalzo J
J Biol Chem; 2003 Aug; 278(34):32100-6. PubMed ID: 12777375
[TBL] [Abstract][Full Text] [Related]
2. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis.
Ushio-Fukai M; Tang Y; Fukai T; Dikalov SI; Ma Y; Fujimoto M; Quinn MT; Pagano PJ; Johnson C; Alexander RW
Circ Res; 2002 Dec; 91(12):1160-7. PubMed ID: 12480817
[TBL] [Abstract][Full Text] [Related]
3. Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS).
Tanimoto T; Jin ZG; Berk BC
J Biol Chem; 2002 Nov; 277(45):42997-3001. PubMed ID: 12226078
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor-dependent down-regulation of Flk-1/KDR involves Cbl-mediated ubiquitination. Consequences on nitric oxide production from endothelial cells.
Duval M; Bédard-Goulet S; Delisle C; Gratton JP
J Biol Chem; 2003 May; 278(22):20091-7. PubMed ID: 12649282
[TBL] [Abstract][Full Text] [Related]
6. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability.
Fukumura D; Gohongi T; Kadambi A; Izumi Y; Ang J; Yun CO; Buerk DG; Huang PL; Jain RK
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2604-9. PubMed ID: 11226286
[TBL] [Abstract][Full Text] [Related]
7. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells.
Miura S; Matsuo Y; Saku K
Hypertension; 2003 May; 41(5):1118-23. PubMed ID: 12654712
[TBL] [Abstract][Full Text] [Related]
8. PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects.
Huang J; Kontos CD
J Biol Chem; 2002 Mar; 277(13):10760-6. PubMed ID: 11784722
[TBL] [Abstract][Full Text] [Related]
9. Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability.
Spyridopoulos I; Luedemann C; Chen D; Kearney M; Chen D; Murohara T; Principe N; Isner JM; Losordo DW
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):901-6. PubMed ID: 12067896
[TBL] [Abstract][Full Text] [Related]
10. Glucose 6-phosphate dehydrogenase is regulated through c-Src-mediated tyrosine phosphorylation in endothelial cells.
Pan S; World CJ; Kovacs CJ; Berk BC
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):895-901. PubMed ID: 19359662
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide and angiogenic activity of endothelial cells: direct or VEGF-dependent effect?
Dulak J; Józkowicz A
Cardiovasc Res; 2002 Dec; 56(3):487-8; author reply 489-91. PubMed ID: 12445890
[No Abstract] [Full Text] [Related]
12. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
13. VEGF induces S1P1 receptors in endothelial cells: Implications for cross-talk between sphingolipid and growth factor receptors.
Igarashi J; Erwin PA; Dantas AP; Chen H; Michel T
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10664-9. PubMed ID: 12963813
[TBL] [Abstract][Full Text] [Related]
14. [Vascular endothelial growth factor and nitric oxide].
Liu YQ; Zhou AR
Sheng Li Ke Xue Jin Zhan; 2000 Jan; 31(1):69-71. PubMed ID: 12532773
[No Abstract] [Full Text] [Related]
15. Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system.
Koistinen P; Siitonen T; Mäntymaa P; Säily M; Kinnula V; Savolainen ER; Soini Y
Leukemia; 2001 Sep; 15(9):1433-41. PubMed ID: 11516104
[TBL] [Abstract][Full Text] [Related]
16. [Transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor induces an angiogenic phenotype in human cultured coronary endothelial cells].
Miura S; Fujino M; Tanigawa H; Matsuo Y; Saku K
Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):104P-105P. PubMed ID: 12491796
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis.
Rössig L; Li H; Fisslthaler B; Urbich C; Fleming I; Förstermann U; Zeiher AM; Dimmeler S
Circ Res; 2002 Nov; 91(9):837-44. PubMed ID: 12411399
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.
Wang H; Keiser JA
Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.
Papapetropoulos A; García-Cardeña G; Madri JA; Sessa WC
J Clin Invest; 1997 Dec; 100(12):3131-9. PubMed ID: 9399960
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
